Chris Anigeron Rallis - Net Worth and Insider Trading
Chris Anigeron Rallis Net Worth
The estimated net worth of Chris Anigeron Rallis is at least $360,562 dollars as of 2024-09-20. Chris Anigeron Rallis is the Director of Fennec Pharmaceuticals Inc and owns about 50,078 shares of Fennec Pharmaceuticals Inc (TSX:FRX) stock worth over $360,562. Details can be seen in Chris Anigeron Rallis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chris Anigeron Rallis has not made any transactions after 2024-04-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chris Anigeron Rallis
Chris Anigeron Rallis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chris Anigeron Rallis owns 1 companies in total, including Fennec Pharmaceuticals Inc (TSX:FRX) .
Click here to see the complete history of Chris Anigeron Rallis’s form 4 insider trades.
Insider Ownership Summary of Chris Anigeron Rallis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:FRX | Fennec Pharmaceuticals Inc | 2024-04-15 | Director |
Chris Anigeron Rallis Latest Holdings Summary
Chris Anigeron Rallis currently owns a total of 1 stock. Chris Anigeron Rallis owns 50,078 shares of Fennec Pharmaceuticals Inc (TSX:FRX) as of April 15, 2024, with a value of $360,562.
Latest Holdings of Chris Anigeron Rallis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:FRX | Fennec Pharmaceuticals Inc | 2024-04-15 | 50,078 | 7.20 | 360,562 |
Holding Weightings of Chris Anigeron Rallis
Chris Anigeron Rallis Form 4 Trading Tracker
According to the SEC Form 4 filings, Chris Anigeron Rallis has made a total of 13 transactions in Fennec Pharmaceuticals Inc (TSX:FRX) over the past 5 years, including 5 buys and 8 sells. The most-recent trade in Fennec Pharmaceuticals Inc is the acquisition of 1,389 shares on April 15, 2024, which cost Chris Anigeron Rallis around $6,769.
Insider Trading History of Chris Anigeron Rallis
- 1
Chris Anigeron Rallis Trading Performance
GuruFocus tracks the stock performance after each of Chris Anigeron Rallis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chris Anigeron Rallis is -16.65%. GuruFocus also compares Chris Anigeron Rallis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chris Anigeron Rallis within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chris Anigeron Rallis's insider trading performs compared to the benchmark.
Performance of Chris Anigeron Rallis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.93 | | | | | |
| Relative Return to S&P 500(%) | -2.69 | | | | | |
Chris Anigeron Rallis Ownership Network
Chris Anigeron Rallis Owned Company Details
What does Fennec Pharmaceuticals Inc do?
Who are the key executives at Fennec Pharmaceuticals Inc?
Chris Anigeron Rallis is the Director of Fennec Pharmaceuticals Inc. Other key executives at Fennec Pharmaceuticals Inc include Director & Senior Officer Rostislav Christov Raykov , Senior Officer Adrian J. Haigh , and Senior Officer Robert Christopher Andrade .
Fennec Pharmaceuticals Inc (TSX:FRX) Insider Trades Summary
Over the past 18 months, Chris Anigeron Rallis made 9 insider transaction in Fennec Pharmaceuticals Inc (TSX:FRX) with a net purchase of 10,816. Other recent insider transactions involving Fennec Pharmaceuticals Inc (TSX:FRX) include a net sale of 0 shares made by Adrian J. Haigh , a net sale of 27,950 shares made by Robert Christopher Andrade , and a net purchase of 67,500 shares made by Rostislav Christov Raykov .
In summary, during the past 3 months, insiders sold 4,862 shares of Fennec Pharmaceuticals Inc (TSX:FRX) in total and bought 0 shares, with a net sale of 4,862 shares. During the past 18 months, 205,144 shares of Fennec Pharmaceuticals Inc (TSX:FRX) were sold and 388,843 shares were bought by its insiders, resulting in a net purchase of 183,699 shares.
Fennec Pharmaceuticals Inc (TSX:FRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fennec Pharmaceuticals Inc Insider Transactions
Chris Anigeron Rallis Mailing Address
Above is the net worth, insider trading, and ownership report for Chris Anigeron Rallis. Currently GuruFocus does not have mailing address information for Chris Anigeron Rallis.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
